133 related articles for article (PubMed ID: 30683441)
1. Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients.
Rizk M; Guilloteau A; Mouillot T; Thiefin G; Bronowicki JP; Richou C; Doffoel M; Diab Assaf M; Hillon P; Cottet V
Nutr Res; 2019 Jan; 61():82-94. PubMed ID: 30683441
[TBL] [Abstract][Full Text] [Related]
2. Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection.
Rossi M; Lipworth L; Maso LD; Talamini R; Montella M; Polesel J; McLaughlin JK; Parpinel M; Franceschi S; Lagiou P; La Vecchia C
Ann Oncol; 2009 Oct; 20(10):1736-40. PubMed ID: 19549710
[TBL] [Abstract][Full Text] [Related]
3. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
4. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Mouillot T; Rizk M; Pais de Barros JP; Gilloteau A; Busson A; Bernard-Chabert B; Thiefin G; Barraud H; Bronowicki JP; Richou C; Di Martino V; Doffoel M; Minello A; Latournerie M; Jouve JL; Brondel L; Brindisi MC; Petit JM; Hillon P; Cottet V;
Aliment Pharmacol Ther; 2020 Nov; 52(9):1503-1515. PubMed ID: 32780481
[TBL] [Abstract][Full Text] [Related]
7. Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis.
Wang YY; Lin SY
Horm Res; 2003; 60(4):185-90. PubMed ID: 14530607
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory potential of diet and risk for hepatocellular cancer in a case-control study from Italy.
Shivappa N; Hébert JR; Polesel J; Zucchetto A; Crispo A; Montella M; Franceschi S; Rossi M; La Vecchia C; Serraino D
Br J Nutr; 2016 Jan; 115(2):324-31. PubMed ID: 26556602
[TBL] [Abstract][Full Text] [Related]
9. Phytoestrogens and liver disease.
Lei B; Roncaglia V; Viganò R; Cremonini C; De Maria N; Del Buono MG; Manenti F; Villa E
Mol Cell Endocrinol; 2002 Jul; 193(1-2):81-4. PubMed ID: 12161005
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity.
Archambeaud I; Auble H; Nahon P; Planche L; Fallot G; Faroux R; Gournay J; Samuel D; Kury S; Féray C
Liver Int; 2015 Jul; 35(7):1872-6. PubMed ID: 25522809
[TBL] [Abstract][Full Text] [Related]
12. High dietary inflammatory index scores are associated with an elevated risk of hepatocellular carcinoma in a case-control study.
Wang XY; Fang AP; Chen PY; Liao GC; Zhang YJ; Shivappa N; Hébert JR; Chen YM; Zhu HL
Food Funct; 2018 Nov; 9(11):5832-5842. PubMed ID: 30357201
[TBL] [Abstract][Full Text] [Related]
13. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
Huang CF; Yeh ML; Tsai PC; Hsieh MH; Yang HL; Hsieh MY; Yang JF; Lin ZY; Chen SC; Wang LY; Dai CY; Huang JF; Chuang WL; Yu ML
J Hepatol; 2014 Jul; 61(1):67-74. PubMed ID: 24613362
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
[TBL] [Abstract][Full Text] [Related]
15. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
Kim BS; Seo YS; Kim YS; Lee CH; Lee HA; Um SH; Yoo JJ; Kim SG; Suh SJ; Jung YK; Ahn SH; Han KH; Yim HJ; Kim SU;
J Gastroenterol Hepatol; 2018 Feb; 33(2):503-510. PubMed ID: 28666070
[TBL] [Abstract][Full Text] [Related]
16. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
17. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.
Koh WP; Dan YY; Goh GB; Jin A; Wang R; Yuan JM
Liver Int; 2016 Jun; 36(6):893-901. PubMed ID: 26443688
[TBL] [Abstract][Full Text] [Related]
18. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
19. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.
Faivre M; Cottet V; Bour JB; Richou C; Valmary-Degano S; Thiefin G; Andreoletti L; Geist C; Schvoerer E; Malvé B; Habersetzer F; Fafi-Kremer S; Binquet C; Jouve JL; Bronowicki JP; Doffoel M; Hillon P; Herbein G; Monnet E; Di Martino V;
J Clin Gastroenterol; 2019 Mar; 53(3):236-241. PubMed ID: 30383568
[TBL] [Abstract][Full Text] [Related]
20. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
